LINC00261 inhibits progression of pancreatic cancer by down-regulating miR-23a-3p.
In conclusion, LINC00261 overexpression repressed cell viability and invasion and enhanced apoptosis by decreasing miR-23a-3p expression in pancreatic cancer cells, indicating a new target for the treatment of pancreatic cancer.
PMID: 32590069 [PubMed - as supplied by publisher]
Source: Archives of Biochemistry and Biophysics - Category: Biochemistry Authors: Wang X, Gao X, Tian J, Zhang R, Qiao Y, Hua X, Shi G Tags: Arch Biochem Biophys Source Type: research
More News: Biochemistry | Cancer | Cancer & Oncology | Databases & Libraries | Epithelial Cancer | Pancreas | Pancreatic Cancer